Neuroxelin is designed to intervene in the cascade of brain injury through multiple mechanisms. It may dampen excitotoxic neuron death by disrupting NMDA receptor signaling pathways, similar to nerinetide (NA-1), which interferes with PSD-95 protein interactions[1]. Additionally, Neuroxelin-class peptides can reduce neuroinflammation by downregulating microglial activation and cytokine release, as demonstrated in studies of apoE-mimetic peptides like CN-105[2]. The peptide may also provide neurotrophic support by promoting synaptic repair and neurogenesis, supporting neuronal survival and vascular repair following acute brain injuries[3][7].